FIRAZYR resources

Support for managing hereditary angioedema (HAE)

Not a real patient.

FIRAZYR is a medicine used to treat acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

Support for managing hereditary angioedema (HAE)

This section provides resources such as our video gallery, as well as a library of informative materials to help you learn about HAE and FIRAZYR.

Video Gallery

Browse through helpful videos full of information, education and real stories from people who have HAE.

See the viewing selection »

Materials for Download

Watch our injection training video, download brochures, or access product information.

Browse resources »

Sign Up for Information

We'll help keep you in the know about HAE and FIRAZYR.

Request info »

Commitment to the HAE Community

Takeda is committed to ensuring people with HAE have access to their acute treatment after our patent for FIRAZYR expires.

Learn more »

What is FIRAZYR?

FIRAZYR is prescribed to treat acute HAE attacks in adults 18 years of age and older.

Get the facts »

OnePath® Support

Product support from a dedicated Patient Support Manager.

Take the next step »